secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001193125-24-170690
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Jessie English resigns from Sensei Biotherapeutics board effective July 1, 2024
--------------------------------------------------------------------------------

- Jessie English, PhD notified Board of resignation on June 26, 2024, effective July 1, 2024.
- Resignation due to personal reasons; no disagreement with Company's operations, policies, or practices.
- No replacement named; Board size reduced to current members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524170690/0001193125-24-170690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524170690/d117545d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-170690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer